Search hospitals > Maryland > Elkton
Union Hospital of Cecil County
Claim this profileElkton, Maryland 21921
Global Leader in Breast Cancer
Global Leader in Ovarian Cancer
Conducts research for Lung Cancer
Conducts research for Breast cancer
Conducts research for Fallopian Tube Cancer
103 reported clinical trials
1 medical researcher
Summary
Union Hospital of Cecil County is a medical facility located in Elkton, Maryland. This center is recognized for care of Breast Cancer, Ovarian Cancer, Lung Cancer, Breast cancer, Fallopian Tube Cancer and other specialties. Union Hospital of Cecil County is involved with conducting 103 clinical trials across 251 conditions. There are 1 research doctors associated with this hospital, such as Gregory A. Masters.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 negative
PR positive
2Ovarian Cancer
Global LeaderStage II
Stage III
Stage IV
Top PIs
Clinical Trials running at Union Hospital of Cecil County
Lung Cancer
Breast Cancer
Cancer
Ovarian Cancer
Colorectal Cancer
Breast cancer
Pancreatic Cancer
Esophageal cancer
Prostate Cancer
Multiple Myeloma
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Treatment Timing
for Non-Small Cell Lung Cancer
This phase III trial compares standard therapy given after surgery (adjuvant) to standard therapy given before and after surgery (perioperative) in treating patients with stage II-IIIB non-small cell lung cancer (NSCLC) that can be removed by surgery (resectable). The usual approach for patients with resectable NSCLC is chemotherapy and/or immunotherapy before surgery, after surgery, or both before and after surgery. This study is being done to find out which approach is better at treating patients with lung cancer. Treatment will be administered according to the current standard of care at the time of enrollment. Chemotherapy options may include cisplatin, carboplatin, pemetrexed, gemcitabine, docetaxel, and vinorelbine at standard doses according to the treating physician. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of tumor cells. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Pemetrexed is in a class of medications called antifolate antineoplastic agents. It works by stopping cells from using folic acid to make deoxyribonucleic acid (DNA) and may kill tumor cells. Gemcitabine is a chemotherapy drug that blocks the cells from making DNA and may kill tumor cells. Docetaxel is in a class of medications called taxanes. It stops tumor cells from growing and dividing and may kill them. Other chemotherapy drugs, such as vinorelbine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading . Immunotherapy with monoclonal antibodies, such as nivolumab, pembrolizumab, and atezolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Starting treatment with chemotherapy and immunotherapy prior to surgery and continuing treatment after surgery may be a more effective treatment option than adjuvant therapy alone in patients with stage II-IIIB resectable NSCLC.
Recruiting2 awards Phase 34 criteria
Cannabis Use
for Breast Cancer
This is a multi-site clinical study enrolling 2000 newly diagnosed patients with breast, colorectal, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer, who are planning to receive one or more systemic cancer directed therapies with chemotherapy and/or (immune checkpoint inhibitors) ICIs.
Recruiting1 award N/A10 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Union Hospital of Cecil County?
Union Hospital of Cecil County is a medical facility located in Elkton, Maryland. This center is recognized for care of Breast Cancer, Ovarian Cancer, Lung Cancer, Breast cancer, Fallopian Tube Cancer and other specialties. Union Hospital of Cecil County is involved with conducting 103 clinical trials across 251 conditions. There are 1 research doctors associated with this hospital, such as Gregory A. Masters.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.